Tufts Clinical and Translational Science Institute Receives $78.4 Million NIH Grant

Tufts Clinical and Translational Science Institute Receives $78.4 Million NIH Grant

Tufts Clinical and Translational Science Institute (CTSI) received $78.4 million Clinical and Translational Science Award from NIH, the fourth consecutive grant since its inception in 2008. The grant provides federal funding over the next seven years to support research services, educational resources and programs, and local, regional, and national initiatives. The award was announced by … Read more

Paralyzed patients can move again with nerve stimulation, confirms HCMC clinical trial

Paralyzed patients can move again with nerve stimulation, confirms HCMC clinical trial

A common implant designed to stimulate the spinal cord is enabling paralyzed patients to move again, a first-of-its-kind discovery in a clinical study at HCMC in Minneapolis. While findings have varied among the roughly 20 study participants, the upshot so far is that people can regain function after spinal cord injury and not simply maintain … Read more

Vistagen to Present Exploratory Safety and Efficacy Data for Fasedienol (PH94B) from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting

Vistagen to Present Exploratory Safety and Efficacy Data for Fasedienol (PH94B) from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting

Last Hour Poster Presentation Highlights Data on Long-Term Open-Label Treatment of As-Needed Intranasal Phasedienol Administrations in a Real-World Setting SOUTH SAN FRANCISCO, California, May 30, 2023–(BUSINESS WIRE)–Vistagen (Nasdaq: VTGN), an advanced clinical-stage biopharmaceutical company aiming to transform the treatment landscape for people living with anxiety, depression, and other central nervous system (CNS) disorders, today announced … Read more